drug

pimavanserin

1 story · latest Aug 4, 2026

Status: FDA approved Apr 2016 · NDA207318, NDA210793
Brand: Nuplazid

Relationships

Developed by ACADIA Pharmaceuticals Inc.

Also known as

pimavanserin tartrate

Timeline

Acadia raises 2026 revenue guidance on DAYBUE and NUPLAZID growth

Aug 4Quarterly updateACADIA Pharmaceuticals Inc.pimavanserin

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.